Sandoz Recalls Bimatoprost Ophthalmic Solution Due to Missing Package Insert
Sandoz Inc is recalling Bimatoprost Ophthalmic Solution 0.03% because the package insert is incorrect or missing. The recall covers 346,929 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The specific defect is a packaging/labeling issue (missing insert) without reported injuries.
Plain-English summary
Sandoz Inc is recalling Bimatoprost Ophthalmic Solution 0.03%, a prescription medication for topical application to the upper eyelid. The recall is due to a labeling defect where the package insert is incorrect or missing. The affected product is manufactured by Alcon Laboratories, Inc. for Sandoz Inc. and is available in 3 mL and 5 mL bottles.
A total of 346,929 bottles are included in this recall. The affected lots have expiration dates ranging from November 30, 2019, to May 31, 2021. The product was distributed nationwide in the United States.
Consumers should stop using the affected product and contact their healthcare provider or pharmacist for further instructions. The recall is classified as Class III by the FDA, indicating that use of the product is not likely to cause adverse health consequences.
The recalled product
- Product
- BIMATOPROST (BIMATOPROST)
- Brand
- BIMATOPROST
- Manufacturer
- Sandoz Inc
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 346,929
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: a) 290635FA
- 290635FB
- Exp. 11/30/2019
- 293230F
- Exp. 6/30/2020
- 294628F
- 301337F
- Exp. 11/30/2020
- 304451FA
- Exp. 1/31/2021. b) 290636FA
- 290636FB
- 290636FC
- 293233FA
- 293233FB
- Exp. 5/31/2020
- 293234FA
- 293234FB
- 294630F
- 301338FA
- 301338FB
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Sandoz Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Sandoz Inc
See all →- LowFocalin XR 5mg capsules carry incorrect or missing lot and expiry
FDA (Drugs) · 2026-06-24
- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateCiprofloxacin and dexamethasone otic suspension recalled following temperature abuse
FDA (Drugs) · 2025-09-17
- SevereBuffered penicillin G potassium vials may actually contain cefazolin for injection
FDA (Drugs) · 2025-07-09
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02